EuroPCR 2020 cancelled due to the outbreak of COVID-19
Paris, France, 5 May 2020. It has been announced that EuroPCR 2020 is cancelled. The 31st edition of the annual World-Leading Course in interventional cardiovascular medicine was due to take place in Paris, France on 19-22 May. The sanitary and legal environment, and in particular the decisions of the French government barring public gatherings for events exceeding 5,000 participants, have resulted in this cancellation as a consequence of the COVID-19 outbreak.
Accompanying EuroPCR’s network through unprecedented times
The organisers have used the weeks leading up to the announcement to safeguard the interests of the vast network of individuals and organisations that support the annual Course, such as clinicians, allied healthcare professionals, industry partners, hotels, audiovisual providers, caterers and booth builders. The sustainability of some of them through the COVID-19 crisis was at stake.
An additional dedicated online resource during the pandemic
PCR continues to provide free and extensive educational resources throughout the year, on PCRonline. Over the last 2-3 months, the sharing of knowledge, experience and practice has remained more actively relevant than ever. A newly developed resource on “Facing Covid-19 with PCR” is providing the interventional community with practical content and advice, at a time when the outbreak is seriously complicating the management of their patients.
Ongoing commitment to independent medical education
The Programme Committee has expressed their strong commitment to providing the community with a full update on late-breaking trials and other essential educational work. The details of how this new initiative will be implemented is to be made known in the coming weeks. As for the next edition of EuroPCR, it is set to take place in Paris, France on 18-21 May 2021.
Notes to editors
EuroPCR is the World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. It has been gathering the interventional cardiovascular community annually since 1989. A total of 11,206 participants were present at the 30th anniversary edition in May 2019, and an additional 4,700 online learners connected to watch a selection of sessions that were made available both live and on replay via PCR Virtual Event on PCRonline.com.
The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, e-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.
Gateways to all PCR activities are available on http://www.
For further information, please contact Célia Vilà: [email protected]